51.7 F
New York
Sunday, October 25, 2020

The Forecast Just Changed on Dare Bioscience Inc. (NASDAQ:DARE)

Must read

Remark Holdings Inc. (NASDAQ:MARK) Finding Zero Support

Remark Holdings Inc. (MARK) shares are trading at lower $1.13. To add more color to this target, the company’s high over the last year...

TEGNA Inc. (NYSE:TGNA) on the Path to Profitability

TEGNA Inc. (TGNA) shares are trading at higher $13.02 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

The Unprecedented Rise of Professional Diversity Network Inc. (NASDAQ:IPDN)

Professional Diversity Network Inc. (IPDN) shares are trading at higher $1.26. To add more color to this target, the company’s high over the last...

Investor Confidence is Falling for Niu Technologies (NASDAQ:NIU)

Niu Technologies (NIU) shares are trading at lower $27.65 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Dare Bioscience Inc. (DARE) shares are trading at higher $1.11 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $2.22 and the low is $0.69. Over the last 52 weeks, DARE is up 50.51% while the S&P 500 is up 18.10%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

DARE Return on Assets is -247.60%. All told, it is clear that, DARE needs to be on your watchlist.

Find out when DARE reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. DARE has a short ratio of 0.20 and outstanding shares of 26.71M.

Company Outlook

DARE has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.42 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.86. Dare Bioscience Inc. DARE also noted assets of $8.57 million at the end of the last quarter. Investors should also keep an eye on sector updates as DARE has historically followed its peers on positive news.

All told, Dare Bioscience Inc. DARE has strung together solid data and demonstrated underlying fundamentals. At its current valuation, DARE represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Dare Bioscience Inc. DARE is now commanding a market cap of 29.03M and a float of 21.61M. DARE is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of DARE stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in DARE, either long or short, and we have not been compensated for this article.

Latest article

Genpact Limited (NYSE:G) Stock is Soaring, Here is Why

Genpact Limited (G) shares are trading at higher $36.98 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Microchip Technology Incorporated (NASDAQ:MCHP) is Holding Steady

Microchip Technology Incorporated (MCHP) shares are trading at higher $112.52 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Investor Confidence is Rising for Sysco Corporation (NYSE:SYY)

Sysco Corporation (SYY) shares are trading at higher $65.21 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Agenus Inc. (NASDAQ:AGEN) is Gaining Momentum on Earnings Catalyst

Agenus Inc. (AGEN) shares are trading at higher $4.08 and the avg recommendation for the stock is Strong Buy. To add more color to...

The Rejuvenation of Costco Wholesale Corporation (NASDAQ:COST)

Costco Wholesale Corporation (COST) shares are trading at lower $375.75 and the avg recommendation for the stock is Moderate Buy, while the current analyst...